能倍乐 思力华噻托溴铵价格贵吗

Helps adults with chronic obstructive pulmonary disease (COPD) breathe easier. COPD is a long-term lung disease that causes shortness of breath and coughing. Respimat Tiotropium helps open the airways, making it easier for air to move in and out of the lungs. Normal use of Respimat, Slava, Tiotropium Bromide can also relieve persistent shortness of breath caused by the disease, helping to minimize the impact of the disease on daily life. According to clinical trial data, it can be seen that Respimat, Sirivar and Tiotropium bromide have significant therapeutic effects. The successful development of this drug is a new treatment option for many patients.

The editor would like to remind everyone that due to the different exchange rates at home and abroad, please consult Medical Travel for the specific prices of Respimat, Siberia, Tiotropium Bromide.

Pharmacological effects of Tiotropium bromide: Tiotropium bromide is a long-acting anticholinergic drug that has similar affinity to five choline receptors (M1-M5). It dilates bronchial smooth muscle by binding to M3 receptors on smooth muscle. This effect is competitive and reversible. In vivo and in vitro studies have shown that this product has a dose-dependent and sustainable 24-hour inhibition of methacholine-induced bronchoconstriction. This product has outstanding localization selectivity for bronchial dilation.

Respimat, Slava, Tiotropium bromide are currently used to treat dyspnea caused by airway obstructive diseases such as bronchial asthma, chronic bronchitis, wheezing bronchitis, and emphysema. It is especially suitable for patients who need to take long-term adrenergic β2 receptor agonists and patients with nocturnal asthma. Special attention should be paid to the following: Respimat, Slivar and Tiotropium bromide are used as once-daily maintenance bronchodilators and cannot be used as rescue treatment drugs for acute episodes of bronchospasm.

Patients must pay attention to medication safety when using it and read the drug instructions in advance.

Recommended related hot articles: /newsDetail/85209.html